Porvair Sciences appoints SPEware Corporation as its exclusive partner

Porvair Sciences, a world leader in applications optimised microplates and microplate equipment has appointed SPEware Corporation (Baldwin Park, CA) as its exclusive partner for supporting and servicing its UltraVap, MiniVap and UltraVap Mistral microplate sample concentration systems.

Steve Knight, Sales & Marketing Director at Porvair Sciences commented:

We have seen US demand for affordable 96-well and 384-well microplate sample concentration systems grow considerably over the last few years.  To enhance local informed support to this rapidly growing community of US customers we have turned to our well established US distribution partner - SPEware Corporation

He added "SPEware Corporation brings over 20-years’ experience of sample preparation to the laboratory using solid phase extraction (SPE) and phospholipid removal/protein crash products, all paired with Positive Pressure Processors and Automation.  This knowledge has helped them to establish Porvair's MiniVap, UltraVap and most recently UltraVap Mistral microplate sample concentrator range in the USA".

porvairpr407-imageA (2)

Drawing upon Porvair’s market leading position in nitrogen blow down microplate sample concentration – the recently launched UltraVap Mistral offers a simple, turnkey solution for integrating an automatic dry down step into your automated liquid handling protocol.  The UltraVap Mistral is fully optimised to work with robotic liquid handling systems from suppliers including Beckman, Hamilton and Tecan and features a “shuttle” design capable of serving and retrieving microplates to and from the robot deck without further need for off-deck handling.

For further information in the USA please contact SPEware Corporation on +1-626-962-0010 or [email protected]. Alternatively please contact Porvair Sciences on +44-1978-666239 or [email protected].

Established in 1992, Porvair Sciences Ltd. has developed internationally recognised expertise in microplate technology and manufacturing serving applications in Drug Discovery, Combinatorial Chemistry, Solid Phase Extraction, Protein Purification, High Throughput Screening, Environmental Analysis, Proteomics and Genomics. Porvair Sciences Ltd. is a wholly owned subsidiary of Porvair plc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chromatrap® - Porvair Sciences Ltd. (2017, August 03). Porvair Sciences appoints SPEware Corporation as its exclusive partner. News-Medical. Retrieved on October 14, 2019 from https://www.news-medical.net/news/20141009/Porvair-Sciences-appoints-SPEware-Corporation-as-its-exclusive-partner.aspx.

  • MLA

    Chromatrap® - Porvair Sciences Ltd. "Porvair Sciences appoints SPEware Corporation as its exclusive partner". News-Medical. 14 October 2019. <https://www.news-medical.net/news/20141009/Porvair-Sciences-appoints-SPEware-Corporation-as-its-exclusive-partner.aspx>.

  • Chicago

    Chromatrap® - Porvair Sciences Ltd. "Porvair Sciences appoints SPEware Corporation as its exclusive partner". News-Medical. https://www.news-medical.net/news/20141009/Porvair-Sciences-appoints-SPEware-Corporation-as-its-exclusive-partner.aspx. (accessed October 14, 2019).

  • Harvard

    Chromatrap® - Porvair Sciences Ltd. 2017. Porvair Sciences appoints SPEware Corporation as its exclusive partner. News-Medical, viewed 14 October 2019, https://www.news-medical.net/news/20141009/Porvair-Sciences-appoints-SPEware-Corporation-as-its-exclusive-partner.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Chromatrap ChIP-Seq kits can deliver streamlined protocol from nanograms of starting material